Literature DB >> 28696454

A cation-exchange controlled core-shell MnS@Bi2S3 theranostic platform for multimodal imaging guided radiation therapy with hyperthermia boost.

Yuhao Li1, Yun Sun, Tianye Cao, Qianqian Su, Zili Li, Mingxian Huang, Ruizhuo Ouyang, Haizhou Chang, Shuping Zhang, Yuqing Miao.   

Abstract

Overtreatment as a crucial modern medicine issue needs to be urgently addressed. Theranostic agents supply a unique platform and integrate multiple diagnosis and therapies to deal with this issue. In this study, a core-shell MnS@Bi2S3 nanostructure was fabricated via two step reactions for tri-modal imaging guided thermo-radio synergistic therapy. The mass ratio between the core and shell of the constructed MnS@Bi2S3 can be precisely controlled via cation exchange reaction. After surface PEGylation, MnS@Bi2S3-PEG nanoparticles exhibited excellent aqueous medium dispersibility for bioapplications. Based on the r1 and r2 relaxivity obtained from the MnS core and the strong near-infrared absorption and X-ray attenuation abilities of the Bi2S3 shell, the intratumoral injected MnS@Bi2S3-PEG can realize in vivo magnetic resonance, computer tomography, and photoacoustic tumor imaging under a single injection dose. Hyperthermia significantly boosts the efficacy of radiation therapy, showing synergistic tumor treatment efficacy. No obvious toxicity is monitored for the treated mice. Our study not only provides a new way to precisely construct the core-shell nanocomposite, but also presents a unique theranostic platform and unifies the solutions for the challenges related with high injection dose and overtreatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28696454     DOI: 10.1039/c7nr02384g

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  3 in total

1.  A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.

Authors:  Alexander P Klapproth; Maxim Shevtsov; Stefan Stangl; Wei Bo Li; Gabriele Multhoff
Journal:  Int J Nanomedicine       Date:  2020-06-30

2.  Bistratal Au@Bi2S3 nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer.

Authors:  Ruizhuo Ouyang; Penghui Cao; Pengpeng Jia; Hui Wang; Tianyu Zong; Chenyu Dai; Jie Yuan; Yuhao Li; Dong Sun; Ning Guo; Yuqing Miao; Shuang Zhou
Journal:  Bioact Mater       Date:  2020-09-04

Review 3.  Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy.

Authors:  Jia Huang; Qiong Huang; Min Liu; Qiaohui Chen; Kelong Ai
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.